Salesforce vs. ServiceNow: Which AI Stock Is a Better Buy?

ServiceNow posted Q4 subscription revenue of $3.47B, +21% YoY, with current RPOs of $12.85B (+25% YoY), Now Assist ACV > $600M, a 57% FCF margin in Q4, and Q1 subscription guidance up to $3.66B (~21.5% YoY); the board authorized an additional $5B buyback and an imminent $2B accelerated repurchase. Salesforce reported organic revenue growth of roughly 8% in fiscal Q4 (down from 9% in Q3) with fiscal‑2027 outlook implying ~7–8% organic growth, Agentforce ARR of $800M (+169% YoY), non‑GAAP operating margin of 34.2%, and RPOs of $72B (+14%); valuation: ServiceNow ~29x forward P/E and ~10x P/S vs Salesforce ~15x forward P/E and ~5x P/S. The author prefers ServiceNow given materially faster growth and stronger cash conversion despite the premium valuation, while noting AI presents both upside and risks for both companies.

Analysis

Service-level workflow platforms that embed generative AI are creating a wedge between pure-play productivity suites and vertical workflow incumbents; winners will be the vendors that turn embedded AI into measurable ROI for customers (reduced handle time, faster case resolution) rather than just new feature revenue. A second-order beneficiary is inference infrastructure — sustained uptake of embedded AI across large enterprise suites increases recurring demand for GPU/accelerator capacity and managed hosting, pressuring cloud margins and benefiting suppliers with differentiated stacks.

Capital return programs that materially shrink free float amplify both upside and downside volatility: buybacks make EPS easier to meet when growth persists but sharply magnify multiple contraction if ARR trajectory slips. The durability of AI-driven monetization is the principal medium-term catalyst; key read-throughs will arrive over the next 2–6 quarters as ACV expansion and churn trends are revealed after initial embeds, while meaningful model-cost arbitrage or commoditization would be a multi-quarter negative.

A calibrated relative/value approach mitigates platform vs. incumbent exposure: capture SaaS growth optionality while hedging macro and AI-execution risk. Operational execution (integrations, retention on AI upsells) and the interplay with infrastructure providers are underappreciated levers that will decide which franchises re-rate versus which trade as mature software names.

Contrarian angle: the market may be underweight the probability that margin expansion at lower-growth incumbents sustains buybacks and FCF conversion, creating a nearer-term floor to downside even if top-line decelerates. Conversely, paying a premium for perpetual high-growth status without multi-year proof of AI-driven net-retention uplift is a crowded trade that risks sharp multiple compression if incremental ARR economics disappoint.

Key Decisions for Investors

• Pair trade (market-neutral): Long NOW (equal-dollar) / Short CRM (equal-dollar), 12–18 month horizon. Target relative outperformance of +35% (NOW up or CRM down) with a hard stop if the pair moves against you by 15% on a relative basis. Rationale: capture differential execution on AI embeds while hedging macro/AI model risk.
• Tactical options trade: Buy NVDA 6–12 month call spread (size 3–5% portfolio) as leveraged exposure to sustained inference demand from large-platform AI rollouts. Reward: asymmetric upside if GPU pricing and utilization stay strong; Risk: time decay and model-sequencing risk if adoption stalls.
• Event-driven long catalyst: Accumulate CRM on weakness into major earnings releases with a 9–12 month horizon (scale in, target +25%) while funding by selling 12–18 month out-of-the-money calls to improve yield. Rationale: margins and cash returns provide downside protection; risk is persistent revenue stagnation leading to multiple compression.
• Risk management: If NOW’s share count-reduction accelerates >10% in 12 months without commensurate ARR retention uplift, trim longs and rotate proceeds into lower-volatility infrastructure plays (NVDA/INTC) to lock in gains and reduce single-name execution risk.